Exchange: NASDAQ·Updated 07:30 PM EDT

ICLR News

News
all
press releases
CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue?
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
More News
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
ICON Releases 2025 ICON Cares Report, Highlighting Progress in Patient Impact, Innovation and Sustainability
ICON plc (NASDAQ: ICLR) (ICON), a world-leading clinical research organisation, today releases its ICON Cares 2025 Report which outlines how the company is delivering on its environmental, social and governance (ESG) priorities with cutting-edge clinical innovation to drive both industry-leading...
Business Wire
Insider Selling: Linda Grais Unloads $138K Of Icon Stock
Linda Grais, Director at Icon (NASDAQ:ICLR), executed a substantial insider sell on August 12, according to an SEC filing. What Happened: Grais opted to sell 841 shares of Icon, according to a Form 4 filing with theread more...
Benzinga
Director Of Icon Makes $138K Sale
Making a noteworthy insider sell on August 12, DR JOHN CLIMAX, Director at Icon (NASDAQ:ICLR), is reported in the latest SEC filing. What Happened: CLIMAX opted to sell 841 shares of Icon, according to a Form 4 filingread more...
Benzinga
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
ICLR's discounted valuation and $23.4B backlog support upside potential, but falling estimates, weaker margins and execution risks argue for patience.
Zacks
Is MEDP Worth Buying as Growth Collides With a Premium Valuation?
Medpace pairs double-digit growth, record awards and a strong balance sheet with a rich valuation, raising the question of whether the premium already prices in its outlook.
Zacks
ICON Announces Pricing of USD 2.15 Billion Notes
ICON plc (NASDAQ: ICLR) (ICON), a world-leading clinical research organization, today announced the pricing by its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the Issuer) of $2.15 billion of senior unsecured notes, consisting of $500 million aggregate principal amount...
Business Wire
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
ICON's 33.2% rally is backed by stronger proposal flow, bookings and backlog, but weaker earnings and margins cloud the recovery.
Zacks
Can MEDP's Record Q2 Bookings Build a Stronger Growth Path for 2027?
Medpace posted record Q2 awards and a stronger book-to-bill ratio, but can backlog conversion and study timing turn renewed demand into stronger 2027 growth?
Zacks

Advertisement|Remove ads.